Answers are grounded in this paper and cite their sources.
Non-steroidal anti-inflammatory drugs (NSAIDs) have the highest intake of all medication in elite and non-elite athletes. The high consumption by athletes (30–50%) participating in team and single-sports leads to the assumption that not only injuries are being treated, but that masking symptoms of minor complaints or post-exercise fatigue might be the primary indication for their intake, without considering their potential harmful side-effects on general health but also on training adaptive processes. Vast information campaign to team physicians since 2011 could not decrease the prescription practice in the past few years highlighted by the persisting high numbers reported during the FIFA World Cups 2002–2014. There is moderate evidence in literature, of earlier return to sport after ankle sprains using NSAIDs systematically, however which is directly related to a decreased range of motion and increased joint instability. Evenmore, recent studies have reported impaired muscular and tendinous adaption to exercise if NSAIDs are ingested. In the early inflammation phase of injured tissue, its use might decrease additional tissue damage especially in muscle injuries, however prolonged intake has been associated for example with delayed fracture healing by intervening with the proliferative phase. NSAIDs are potent analgesic medications, but due to their anti-inflammatory property their intake should be wisely indicated; inhibiting early excessive inflammation without decreasing tissue-healing potential. Their use should be more controlled by the health care specialist especially by sports physicians. Neither over-the-counter use nor administration by non-medical staff should be supported; alternative treatment options however need to be educated.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: